Generic Rebetol meeting
Executive Summary
Three Rivers Pharmaceuticals meets with FDA Chief Counsel Daniel Troy to discuss "labeling issues" for generic version of Schering-Plough's Rebetol (ribavirin) June 24. Three Rivers expects 2003 launch for the generic...